Manual lymph drainage in systemic sclerosis
Not Applicable
Completed
- Conditions
- Systemic sclerosisMusculoskeletal Diseases
- Registration Number
- ISRCTN24123906
- Lead Sponsor
- niversity of Florence (Italy)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
1. Both males and females, no age limits
2. Systemic sclerosis patients with oedematous hands fulfilling the American College of Rheumatology (ACR) criteria
Exclusion Criteria
1. Patients that do not meet the inclusion criteria
2. Ongoing infections and thrombosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> The following items assessed at baseline, at the end of treatment (after 5 weeks) and after 9 weeks of follow-up.<br> 1. Hands volume assessed by volumetric test<br> 2. Hands function evaluated by Hand Mobility in Scleroderma (HAMIS) test, assessed in both hands<br>
- Secondary Outcome Measures
Name Time Method <br> The following items assessed at baseline, at the end of treatment (after 5 weeks) and after 9 weeks of follow-up:<br> 1. 4 visual assessment scales (VAS) 0-10 (0= best condition;10= worst condition) by which the patient self-assesses the entity (in the previous week) of<br> 1.1. Hand oedema<br> 1.2. Hand pain<br> 1.3. The interference of hand oedema on the daily activities<br> 1.4. The inferference of hand pain on the daily activities.<br> 2. Quality of life, assessed by the 36-item Short Form (SF-36) Health Survey and Health Assessment Questionnaire (HAQ)<br>